Shatavari for Menopausal Symptoms Study
This study is testing two dietary supplements, Shatavari extract and a combination of Shatavari and Ashwagandha extracts, to see if they can help with menopausal symptoms like hot flashes and mood changes. Researchers want to compare these supplements to a placebo (an inactive substance like a sugar pill) to understand their effectiveness and safety. You might be able to join if you are a woman between 45 and 65 years old, have an intact uterus and ovaries, and are experiencing menopausal symptoms and irregular periods. The study aims to enroll 51 participants, but the current recruitment status is unclear.
- Study design
- This is a randomized, double-blind, placebo-controlled study with three groups. About 51 participants will be randomly assigned to receive Shatavari, Shatavari plus Ashwagandha, or a placebo.
- What's involved
- You would take one capsule daily for 8 weeks. You will have visits at the beginning, after 4 weeks, and at the end of 8 weeks, which include physical exams and blood draws.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your menopausal symptoms will be assessed at the start of the study, after 4 weeks, and at the end of the 8-week treatment period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Menopause Rating Scale (MRS)MRS assessment will be done at Visit 1, Screening Visit/ Enrolment Visit/ Baseline Visit, (Day 1), Visit 2 (Week 4), and Visit 3- End of study visit, (Week 8).
The scale consisted of 11 items, ranging from no symptoms to very severe symptoms. The total score of the MRS ranges from 0 (asymptomatic) to 44 (highest degree of complaints). The minimal/maximal scores vary between the three dimensions, depending on the number of complaints allocated to the respective dimension of symptoms.